Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H GLICK

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Journal of Affective Disorders|March 1, 2002
Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'M S Bauer, W O Williford, E E Dawson, et al.
Pharmacology & Therapeutics|January 1, 1988
Pharmacokinetics of WR-2721L M Shaw, D Glover, A Turrisi, et al.
The New England Journal of Medicine|April 8, 1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaR I Fisher, E R Gaynor, S Dahlberg, et al.
Medical Humanities|February 24, 2025
Engineering organs, hopes and hybridity: considerations on the social potentialities of xenotransplantationJohannes Kögel, Peta S Cook, Nik Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Toxicity of WR-2721 administered in single and multiple dosesM M Kligerman, D J Glover, A T Turrisi, et al.
Cancer|May 1, 1983
The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimenM M Oken, W G Costello, G J Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma StudyR I Fisher, E R Gaynor, S Dahlberg, et al.
Lung Cancer (Amsterdam, Netherlands)|October 8, 1999
A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586)W J Tester, K M Kim, R L Krigel, et al.
Health Economics|December 9, 1998
Resource costing for multinational neurologic clinical trials: methods and resultsK Schulman, J Burke, M Drummond, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year updateJ H Glick, B L Fowble, D G Haller, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Journal of Affective Disorders|March 1, 2002
Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'M S Bauer, W O Williford, E E Dawson, et al.
Pharmacology & Therapeutics|January 1, 1988
Pharmacokinetics of WR-2721L M Shaw, D Glover, A Turrisi, et al.
The New England Journal of Medicine|April 8, 1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaR I Fisher, E R Gaynor, S Dahlberg, et al.
Medical Humanities|February 24, 2025
Engineering organs, hopes and hybridity: considerations on the social potentialities of xenotransplantationJohannes Kögel, Peta S Cook, Nik Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Toxicity of WR-2721 administered in single and multiple dosesM M Kligerman, D J Glover, A T Turrisi, et al.
Cancer|May 1, 1983
The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimenM M Oken, W G Costello, G J Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma StudyR I Fisher, E R Gaynor, S Dahlberg, et al.
Lung Cancer (Amsterdam, Netherlands)|October 8, 1999
A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586)W J Tester, K M Kim, R L Krigel, et al.
Health Economics|December 9, 1998
Resource costing for multinational neurologic clinical trials: methods and resultsK Schulman, J Burke, M Drummond, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year updateJ H Glick, B L Fowble, D G Haller, et al.
Pageof 23